Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan P Dutz

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
JAAD Case Reports|August 17, 2019
New-onset autoantibody-mediated nephritis during ustekinumab therapy for psoriasis in patients with and without prior systemic lupus erythematosusAyida Al Khalili, Leah Scott, Jan P Dutz
Clinical Immunology (Orlando, Fla.)|June 21, 2014
Targeting the IL-17/IFN-γ axis as a potential new clinical therapy for type 1 diabetesAshish K Marwaha, Sara Tan, Jan P Dutz
CJEM|January 6, 2026
Just the facts: diagnosis and management of Stevens-Johnson syndrome/toxic epidermal necrolysisJensen Yeung, Marlene Dytoc, Eric Mutter, et al.
JAAD Case Reports|August 8, 2019
Lymphocyte-variant hypereosinophilic syndrome presenting as chronic dermatitis and responding to mycophenolic acidCarol Dou, Luke Y C Chen, Jan P Dutz
Journal of Psoriasis and Psoriatic Arthritis|September 19, 2024
A Retrospective Study on the Effectiveness of Ixekizumab After Treatment With Secukinumab for Patients With Active Psoriatic ArthritisSaman Darabian, Maziar Badii, Jan P Dutz, et al.
Archives of Dermatology|August 17, 2011
Usefulness of Interferon-γ release assays in the diagnosis of erythema induratumCristián Vera-Kellet, Laurenna Peters, Kevin Elwood, et al.
JAMA Dermatology|April 4, 2014
D-dimer levels as a marker of cutaneous disease activity: case reports of cutaneous polyarteritis nodosa and atypical recurrent urticariaMark G Kirchhof, Agnes Y Y Lee, Jan P Dutz
Clinical and Vaccine Immunology : CVI|January 7, 2014
Topical CpG adjuvantation of a protein-based vaccine induces protective immunity to Listeria monocytogenesWing Ki Cheng, Kathleen Wee, Tobias R Kollmann, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|June 28, 2021
Combination Therapy With Tofacitinib and IL-12/23, IL-23, or IL-17A Inhibition for the Treatment of Refractory Psoriatic Arthritis: A Case SeriesMegan Shurey, Ashley Yip, Olga Ziouzina, et al.
International Journal of Dermatology|July 5, 2020
Infection risk of dermatologic therapeutics during the COVID-19 pandemic: an evidence-based recalibrationFeras M Ghazawi, Megan Lim, Jan P Dutz, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
JAAD Case Reports|August 17, 2019
New-onset autoantibody-mediated nephritis during ustekinumab therapy for psoriasis in patients with and without prior systemic lupus erythematosusAyida Al Khalili, Leah Scott, Jan P Dutz
Clinical Immunology (Orlando, Fla.)|June 21, 2014
Targeting the IL-17/IFN-γ axis as a potential new clinical therapy for type 1 diabetesAshish K Marwaha, Sara Tan, Jan P Dutz
CJEM|January 6, 2026
Just the facts: diagnosis and management of Stevens-Johnson syndrome/toxic epidermal necrolysisJensen Yeung, Marlene Dytoc, Eric Mutter, et al.
JAAD Case Reports|August 8, 2019
Lymphocyte-variant hypereosinophilic syndrome presenting as chronic dermatitis and responding to mycophenolic acidCarol Dou, Luke Y C Chen, Jan P Dutz
Journal of Psoriasis and Psoriatic Arthritis|September 19, 2024
A Retrospective Study on the Effectiveness of Ixekizumab After Treatment With Secukinumab for Patients With Active Psoriatic ArthritisSaman Darabian, Maziar Badii, Jan P Dutz, et al.
Archives of Dermatology|August 17, 2011
Usefulness of Interferon-γ release assays in the diagnosis of erythema induratumCristián Vera-Kellet, Laurenna Peters, Kevin Elwood, et al.
JAMA Dermatology|April 4, 2014
D-dimer levels as a marker of cutaneous disease activity: case reports of cutaneous polyarteritis nodosa and atypical recurrent urticariaMark G Kirchhof, Agnes Y Y Lee, Jan P Dutz
Clinical and Vaccine Immunology : CVI|January 7, 2014
Topical CpG adjuvantation of a protein-based vaccine induces protective immunity to Listeria monocytogenesWing Ki Cheng, Kathleen Wee, Tobias R Kollmann, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|June 28, 2021
Combination Therapy With Tofacitinib and IL-12/23, IL-23, or IL-17A Inhibition for the Treatment of Refractory Psoriatic Arthritis: A Case SeriesMegan Shurey, Ashley Yip, Olga Ziouzina, et al.
International Journal of Dermatology|July 5, 2020
Infection risk of dermatologic therapeutics during the COVID-19 pandemic: an evidence-based recalibrationFeras M Ghazawi, Megan Lim, Jan P Dutz, et al.
Pageof 10